| scholarly article | Q13442814 |
| P50 | author | Héctor Escobar Morreale | Q43185421 |
| José I Botella-Carretero | Q56125739 | ||
| P2093 | author name string | José L San Millán | |
| Gemma Villuendas | |||
| José Sancho | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| interleukins | Q194908 | ||
| polycystic ovary | Q5547896 | ||
| polycystic ovary syndrome | Q500816 | ||
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 806-811 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity | |
| P478 | volume | 89 |
| Q35941368 | A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus |
| Q61762737 | Adipose Tissue Interleukin-18 mRNA and Plasma Interleukin-18: Effect of Obesity and Exercise* |
| Q46685753 | Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects |
| Q36287002 | Association of interleukin-18 gene polymorphism with body mass index in women |
| Q34273781 | Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population |
| Q36180254 | Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study. |
| Q36287892 | Cardiometabolic aspects of the polycystic ovary syndrome. |
| Q92773936 | Circular RNA expression profiling of granulosa cells in women of reproductive age with polycystic ovary syndrome |
| Q46625047 | Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass. |
| Q34817037 | Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. |
| Q47977267 | Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome |
| Q51745836 | Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. |
| Q36617125 | Cytokines in type 2 diabetes. |
| Q83864443 | Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance |
| Q37039725 | Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management |
| Q47280913 | Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients |
| Q51490876 | Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. |
| Q51498308 | Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus. |
| Q35189080 | Endogenous interleukin 18 suppresses hyperglycemia and hyperinsulinemia during the acute phase of endotoxemia in mice. |
| Q51359264 | Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome. |
| Q48534581 | Expression of mRNA and protein of IL-18 and its receptor in human follicular granulosa cells |
| Q36671813 | Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats |
| Q36005876 | IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance |
| Q43186682 | Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome |
| Q83979184 | Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance |
| Q46960389 | Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin |
| Q36739203 | Indices of low-grade inflammation in polycystic ovary syndrome |
| Q51854353 | Induction of secretory leukocyte protease inhibitor (SLPI) in estradiol valerate (EV) induced polycystic ovary. |
| Q38034273 | Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family |
| Q37420086 | Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. |
| Q33838823 | Insulin resistance and serum levels of interleukin-17 and interleukin-18 in normal pregnancy |
| Q34137763 | Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions |
| Q42817301 | Interleukin-18 enhances glucose uptake in 3T3-L1 adipocytes |
| Q38685111 | Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study. |
| Q81681379 | Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus |
| Q50021277 | Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. |
| Q54372472 | Involvement of interleukin 18 in lens opacification of Otsuka Long-Evans Tokushima Fatty rats, a model of human type 2 diabetes. |
| Q35633277 | Is PCOS an inflammatory process? |
| Q34560258 | Is interleukin-18 associated with polycystic ovary syndrome? |
| Q37604621 | Is there a link between polycystic ovary syndrome and non-thyroidal illness syndrome? |
| Q38007180 | Mediators of chronic inflammation in polycystic ovarian syndrome |
| Q42482692 | Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients |
| Q21131282 | PI3K: An Attractive Candidate for the Central Integration of Metabolism and Reproduction |
| Q34238563 | Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance. |
| Q57606221 | Polycystic Ovary Syndrome |
| Q37990356 | Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
| Q36194452 | Polycystic ovary syndrome and gynecological cancers: is there a link? |
| Q35124537 | Polycystic ovary syndrome: current status and future perspective |
| Q37296393 | Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance |
| Q34393333 | Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study. |
| Q95643265 | Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies |
| Q35740949 | Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients |
| Q35754543 | Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity |
| Q92915706 | The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects |
| Q90647016 | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
| Q80184148 | The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event |
| Q51498830 | The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women. |
| Q43119904 | The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome |
| Q79566798 | [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome] |
| Q42853651 | −607 C/A polymorphism in the promoter of IL-18 gene is associated with 2 h post-loading plasma glucose level in Chinese |
Search more.